Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate IDEXX Laboratories, Inc. before investing.

In this article, we go over a few key elements for understanding IDEXX Laboratories, Inc.’s stock price such as:

• IDEXX Laboratories, Inc.’s current stock price and volume
• Why IDEXX Laboratories, Inc.’s stock price changed recently
• Upgrades and downgrades for IDXX from analysts
• IDXX’s stock price momentum as measured by its relative strength

About IDEXX Laboratories, Inc. (IDXX)

Before we jump into IDEXX Laboratories, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Want to learn more about IDEXX Laboratories, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about IDEXX Laboratories, Inc..

What Caused IDEXX Laboratories, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 30, 2025, there were 4 analysts who downgraded IDEXX Laboratories, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate IDEXX Laboratories, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on IDEXX Laboratories, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

IDEXX Laboratories, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about IDEXX Laboratories, Inc. (IDXX) by visiting AAII Stock Evaluator.

Relative Price Strength of IDEXX Laboratories, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 30, 2025, IDEXX Laboratories, Inc. has a weighted four-quarter relative price strength of -2.11%, which translates to a Momentum Score of 49 and is considered to be Average.

Want to learn more about how IDEXX Laboratories, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

IDEXX Laboratories, Inc. Stock Price: Bottom Line

As of May 1, 2025, IDEXX Laboratories, Inc.’s stock price is $470.940, which is up 8.85% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like IDEXX Laboratories, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.